2m 2m 2m 2m 2m 2m 2m
SAVARA (SVRA)
NASDAQ
$4.79-$0.20 (-4.09%)
Price as of Nov 12, 2026 9:42 AM EST- $1.0BMarket Cap
- 21.12%1-Year Change
- BiotechnologyIndustry
SAVARA (SVRA)
$4.79-$0.20 (-4.09%)
SVRA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.99 | ||
Change | +$0.07 (+1.42%) | ||
Open | $4.99 | ||
High | $5.21 | ||
Low | $4.91 | ||
Previous Close | $4.92 | ||
Volume | 9,257,085 | ||
30-Day Average Volume | 2,768,777 | ||
1-Week Change | 7.08% | ||
1-Month Change | 1.42% | ||
1-Year Change | 21.12% | ||
3-Year Change | 43.80% | ||
5-Year Change | 330.17% | ||
Fundamentals | |||
Shares Outstanding | 205.5M | ||
Total Assets | $155.9M | ||
Market Cap | $1.0B | ||
Enterprise Value | $1.0B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$43.0M | ||
Free Cash Flow | -$42.8M | ||
EBIT | -$43.0M | ||
EBITDA | -$42.9M | ||
Net Working Capital | $125.5M | ||
EPS | -$0.17 | ||
Enterprise Value/EBITDA | -24 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 10 | ||
P/E | -29 | ||
PEG | 5 | ||
Price/Free Cash Flow | -24 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue